Kirk R. Huntsman's most recent trade in Vivos Therapeutics Inc was a trade of 315,421 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Nov. 26, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Vivos Therapeutics Inc | Kirk R. Huntsman | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2024 | 315,421 | 364,755 | - | - | Stock Option (Right to Buy) | |
| Vivos Therapeutics Inc | R. Kirk Huntsman | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 20,000 | 49,334 | - | - | Stock Option (Right to Buy) | |
| Vivos Therapeutics Inc | R. Kirk Huntsman | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.53 per share. | 20 Jun 2023 | 14,000 | 86,521 | - | 0.5 | 7,420 | Common Stock |
| Vivos Therapeutics Inc | R. Kirk Huntsman | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.54 per share. | 15 Jun 2023 | 10,000 | 67,521 | - | 0.5 | 5,400 | Common Stock |
| Vivos Therapeutics Inc | R. Kirk Huntsman | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.53 per share. | 15 Jun 2023 | 5,000 | 72,521 | - | 0.5 | 2,650 | Common Stock |
| Vivos Therapeutics Inc | R. Kirk Huntsman | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.52 per share. | 15 Jun 2023 | 21 | 57,521 | - | 0.5 | 11 | Common Stock |
| Vivos Therapeutics Inc | R. Kirk Huntsman | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.49 per share. | 14 Jun 2023 | 10,000 | 57,500 | - | 0.5 | 4,900 | Common Stock |
| Vivos Therapeutics Inc | R. Kirk Huntsman | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2022 | 333,334 | 333,334 | - | - | Stock Option (Right to Buy) | |
| Vivos Therapeutics Inc | R. Kirk Huntsman | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2022 | 150,000 | 483,334 | - | - | Stock Option (Right to Buy) | |
| Vivos Therapeutics Inc | R. Kirk Huntsman | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.50 per share. | 23 Dec 2022 | 20,000 | 47,500 | - | 0.5 | 10,000 | Common Stock |
| Vivos Therapeutics Inc | R. Kirk Huntsman | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.03 per share. | 31 May 2022 | 8,000 | 23,500 | - | 2.0 | 16,240 | Common Stock |
| Vivos Therapeutics Inc | R. Kirk Huntsman | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.83 per share. | 31 May 2022 | 4,000 | 27,500 | - | 1.8 | 7,320 | Common Stock |
| Vivos Therapeutics Inc | R. Kirk Huntsman | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2022 | 125,000 | 125,000 | - | - | Stock Option (Right to Buy) | |
| Vivos Therapeutics Inc | R. Kirk Huntsman | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 4.31 per share. | 21 Sep 2021 | 5,000 | 15,500 | - | 4.3 | 21,550 | Common Stock |
| Vivos Therapeutics Inc | R. Kirk Huntsman | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 3.00 per share. | 17 Aug 2021 | 5,000 | 10,500 | - | 3 | 15,000 | Common Stock |
| Vivos Therapeutics Inc | R. Kirk Huntsman | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 5.38 per share. | 25 May 2021 | 4,000 | 5,500 | - | 5.4 | 21,520 | Common Stock |